NEW BRUNSWICK, N.J. / Aug 07, 2023 / Business Wire / Johnson & Johnson (NYSE: JNJ) will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7th. Ashley McEvoy, EVP, Worldwide Chairman, MedTech along with executives from Abiomed will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
| Last Trade: | US$149.84 |
| Daily Change: | -4.30 -2.79 |
| Daily Volume: | 2,586,491 |
| Market Cap: | US$361.110B |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
